Skip to main content

Navigation group

Type at least 3 characters
1,067 articles

Articles

Brief Research Report

Published on 02 Feb 2022

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

in Gastrointestinal and Hepatic Pharmacology

  • Alana Aragón-Herrera
  • Manuel Otero-Santiago
  • Laura Anido-Varela
  • Sandra Moraña-Fernández
  • Manuel Campos-Toimil
  • Tomás García-Caballero
  • Luis Barral
  • Estefanía Tarazón
  • Esther Roselló-Lletí
  • Manuel Portolés
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology
doi 10.3389/fphar.2022.827033
  • 4,359 views
  • 5 citations

Brief Research Report

Published on 20 Jan 2022

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study

in Gastrointestinal and Hepatic Pharmacology

  • Guilherme Grossi Lopes Cançado
  • Cláudia Alves Couto
  • Laura Vilar Guedes
  • Michelle Harriz Braga
  • Débora Raquel Benedita Terrabuio
  • Eduardo Luiz Rachid Cançado
  • Maria Lucia Gomes Ferraz
  • Cristiane Alves Villela-Nogueira
  • Mateus Jorge Nardelli
  • Luciana Costa Faria
Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
Frontiers in Pharmacology
doi 10.3389/fphar.2021.818089
  • 4,584 views
  • 5 citations